Aims and Scope of Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley (European Organisation for Research and Treatment of Cancer). Less
Key Metrics
CiteScore 

3.4
H-Index 

60
Impact Factor 

< 5
SJR 

Q2Health Policy

SNIP 

0.9
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics and Outcomes Research Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Review of Pharmacoeconomics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Review of Pharmacoeconomics and Outcomes Research
Principles of selecting cost-effectiveness thresholds in price-taker countries
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Comparative landscape of artificial intelligence-assisted systematic literature reviews
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Regulatory approval trends and market access implications: a multiregional comparative framework for New and supplemental Drug applications (2020-2025)
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Principles of selecting cost-effectiveness thresholds in price-taker countries
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Comparative landscape of artificial intelligence-assisted systematic literature reviews
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Regulatory approval trends and market access implications: a multiregional comparative framework for New and supplemental Drug applications (2020-2025)
- 9 Aug 2026
- Expert Review of Pharmacoeconomics & Outcomes Research